Nung-Yu Hsu

Title: Nung-Yu Hsu: Innovator in SARS-CoV-2 Treatment

Introduction

Nung-Yu Hsu is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical research, particularly in the fight against viral infections. His innovative approach has led to the development of a method aimed at combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Latest Patents

Nung-Yu Hsu holds 1 patent for his groundbreaking method against SARS-CoV-2 infection. The patent discloses a method that includes administering a first active ingredient, selected from methotrexate (MIX) and its pharmaceutically acceptable salts, alongside a second active ingredient, which includes remdesivir and its pharmaceutically acceptable salts. The method specifies a molar ratio of the first active ingredient to the second active ingredient ranging from 1:13 to 1:25.

Career Highlights

Hsu is affiliated with National Yang Ming Chiao Tung University, where he continues to engage in research and development. His work is pivotal in addressing public health challenges posed by viral infections, particularly in the context of the ongoing global pandemic.

Collaborations

Some of his notable coworkers include Chih-Heng Huang and Jinn-Moon Yang, who contribute to the collaborative efforts in research and innovation at the university.

Conclusion

Nung-Yu Hsu's contributions to the field of medical research, particularly through his patent for a method against SARS-CoV-2 infection, highlight his role as an innovator in combating viral diseases. His work continues to inspire advancements in medical treatments and public health strategies.